HomeBUSINESS
BUSINESS

Eisai to Quit Generic Supply Biz, Transfer Subsidiary to Nichi-Iko
(Mar.29.2018)

Nichi-Iko President Yuichi Tamura (left), Eisai CEO Haruo Naito
Eisai will bow out of the generic supply business by transferring the entire stake in its wholly owned subsidiary, Elmed Eisai, to leading Japanese generic maker Nichi-Iko Pharmaceutical for roughly 17.12 billion yen, with the transaction expected to be completed in April 2019 ...
(LOG IN FOR FULL STORY)

News Calendar